The Valley Desk

NCT02504294 · Interventional trial

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Overall registry status Completed

Phase 3

Conditions Chronic Kidney Disease (CKD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov